
Alegeți eticheta dumneavoastră
afișată direct pe flaconP21
Cognition
- Livrare din Germania
Comandă
- DHL cu urmărire
- Ambalare discretă
Pe scurt
P21 în cifre
Valorile principale din lexiconul nostru.
Articolul complet din lexicon- Class
- CNTF mimetic / BDNF enhancer
- Half-life
- shorthence 2 doses per week
- Use
- Subcutaneous2x per week
- Sizes
- 10 mg1 size in the shop
What studies show
All 3 sources in the lexicon- Kazim et al., Neurobiology of Disease, 2014
- Khatoon et al., Journal of Alzheimer's Disease, 2015
- Bolognin et al., Neurobiology of Aging, 2014
Pentru P21 nu există încă o analiză de laborator. Votați pentru elTestați-l singur, noi plătim jumătateToate analizele de laborator
Informații
Totul despre P21
Informații detaliate în curând.
Util de adăugat
De ce aveți nevoie în plus
Apa bacteriostatică se adaugă automat în coș. Seringi și tampoane cu un singur clic.
Seringi de insulină
10 buc. · 5.50 €
Tampoane cu alcool
50 buc. · 10 €
Câtă apă?
Unități pe seringă pentru mărimea flaconului dumneavoastră.
Deschideți calculatorul →Is P21 approved or studied in humans?
No. There is no approval and as of 26 October 2026 ClinicalTrials.gov lists no trial with P021. According to a conflict of interest statement from 2024 a company of the developer intends to develop P021 as a medicine. So far all data come from cells and animals.
What is P21 made of?
Of a tetrapeptide from the most active region of CNTF, plus a glycine with an adamantane group at the end. The formula is Ac-DGGL(A)G-NH2. The adamantane is meant to ease the way into the brain and slow breakdown by enzymes. The first paper from 2010 called the peptide P21, later ones P021.
What did the Alzheimer models show?
Mice with three Alzheimer genes received P021 for twelve months from an age of 9 to 10 months. Abnormal tau declined clearly, soluble amyloid fell, memory and the formation of new nerve cells improved. When dosing started at 3 months, tau and amyloid changes largely did not appear and fewer animals died. Even dosing only before and shortly after birth later reduced tau changes and amyloid plaques.
What did old rats show?
Rats aged 22 to 24 months lost less learning and memory performance with P021 and made more BDNF and more new nerve cells. A second paper showed that P021 reaches the brain and lowered the tau level in the cerebrospinal fluid to that of young rats, but not amyloid.
Are there findings outside Alzheimer's?
Yes, mixed ones. In a mouse model of Down syndrome dosing before and shortly after birth prevented developmental delay and later memory problems. In a model of CDKL5 disorder P021 helped in cell culture, but in mice BDNF did not rise and the benefit stayed small.
How was P021 given in the studies?
In the animal studies mostly with the food, so by mouth, often over many months. The lexicon entry instead describes dosing under the skin. There are no human data on that.
Which side effects are known?
There are no solid data because P021 has never been tested in humans. In old rats it caused no detectable immune reaction. That cannot be transferred to humans.
Produse asemănătoare
Produse similare
Selank
Peptide · Cogniție și somn Cogniție și somn
3 mărimi
Testat în laborator
= de la 10 €/flacon
Selank Nasal
Peptide · Cogniție și somn Cogniție și somn
1 mărime
Semax
Peptide · Cogniție și somn Cogniție și somn
3 mărimi
Testat în laborator
= de la 10 €/flacon
Semax Nasal
Peptide · Cogniție și somn Cogniție și somn
1 mărime
P21